Connor, Clark & Lunn Investment Management (CC&L)’s Select Medical SEM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.33M | Buy |
+219,387
| New | +$3.33M | 0.01% | 701 |
|
|
2024
Q4 | – | Sell |
-70,246
| Closed | -$1.32M | – | 1617 |
|
|
2024
Q3 | $1.32M | Buy |
+70,246
| New | +$1.32M | 0.01% | 796 |
|
|
2023
Q4 | – | Sell |
-30,941
| Closed | -$421K | – | 1539 |
|
|
2023
Q3 | $421K | Sell |
30,941
-7,541
| -20% | -$103K | ﹤0.01% | 1060 |
|
|
2023
Q2 | $661K | Buy |
+38,482
| New | +$661K | ﹤0.01% | 916 |
|
|
2022
Q4 | – | Sell |
-108,320
| Closed | -$1.29M | – | 1402 |
|
|
2022
Q3 | $1.29M | Buy |
+108,320
| New | +$1.29M | 0.01% | 596 |
|
|
2022
Q2 | – | Sell |
-101,269
| Closed | -$1.31M | – | 1188 |
|
|
2022
Q1 | $1.31M | Buy |
+101,269
| New | +$1.31M | 0.01% | 608 |
|
|
2020
Q1 | – | Sell |
-26,402
| Closed | -$332K | – | 1152 |
|
|
2019
Q4 | $332K | Buy |
+26,402
| New | +$332K | ﹤0.01% | 741 |
|
|
2016
Q3 | – | Sell |
-204,021
| Closed | -$1.2M | – | 906 |
|
|
2016
Q2 | $1.2M | Sell |
204,021
-64,217
| -24% | -$376K | 0.01% | 450 |
|
|
2016
Q1 | $1.71M | Sell |
268,238
-43,756
| -14% | -$278K | 0.01% | 358 |
|
|
2015
Q4 | $2M | Buy |
311,994
+34,151
| +12% | +$219K | 0.02% | 341 |
|
|
2015
Q3 | $1.62M | Buy |
277,843
+53,453
| +24% | +$311K | 0.01% | 326 |
|
|
2015
Q2 | $1.96M | Buy |
224,390
+15,033
| +7% | +$131K | 0.02% | 244 |
|
|
2015
Q1 | $1.67M | Sell |
209,357
-159,430
| -43% | -$1.27M | 0.01% | 248 |
|
|
2014
Q4 | $2.86M | Sell |
368,787
-197,293
| -35% | -$1.53M | 0.02% | 199 |
|
|
2014
Q3 | $3.67M | Buy |
566,080
+405,536
| +253% | +$2.63M | 0.03% | 164 |
|
|
2014
Q2 | $1.44M | Buy |
160,544
+74,240
| +86% | +$665K | 0.01% | 278 |
|
|
2014
Q1 | $639K | Buy |
86,304
+43,430
| +101% | +$322K | ﹤0.01% | 446 |
|
|
2013
Q4 | $285K | Sell |
42,874
-49,369
| -54% | -$328K | ﹤0.01% | 611 |
|
|
2013
Q3 | $412K | Sell |
92,243
-83,520
| -48% | -$373K | ﹤0.01% | 395 |
|
|
2013
Q2 | $819K | Buy |
+175,763
| New | +$819K | 0.01% | 285 |
|